Viewing StudyNCT00004070



Ignite Creation Date: 2024-05-05 @ 11:08 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004070
Status: COMPLETED
Last Update Posted: 2017-04-20
First Post: 1999-12-10

Brief Title: Gene Therapy in Treating Patients With Unresectable Recurrent or Refractory Head and Neck Cancer
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Head and Neck Cancer
Keywords:
Name View
recurrent metastatic squamous neck cancer with occult primary View
metastatic squamous neck cancer with occult primary squamous cell carcinoma View
stage III squamous cell carcinoma of the lip and oral cavity View
stage IV squamous cell carcinoma of the lip and oral cavity View
recurrent squamous cell carcinoma of the lip and oral cavity View
stage III squamous cell carcinoma of the oropharynx View
stage IV squamous cell carcinoma of the oropharynx View
recurrent squamous cell carcinoma of the oropharynx View
stage III squamous cell carcinoma of the nasopharynx View
stage IV squamous cell carcinoma of the nasopharynx View
recurrent squamous cell carcinoma of the nasopharynx View
stage III squamous cell carcinoma of the hypopharynx View
stage IV squamous cell carcinoma of the hypopharynx View
recurrent squamous cell carcinoma of the hypopharynx View
stage III squamous cell carcinoma of the larynx View
stage IV squamous cell carcinoma of the larynx View
recurrent squamous cell carcinoma of the larynx View
stage III squamous cell carcinoma of the paranasal sinus and nasal cavity View
stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity View
recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity View